Neurodegenerative Diseases

2 researchers across 2 institutions

2 Researchers
2 Institutions
0 Grant PIs
0 High Impact

Research in neurodegenerative diseases investigates the biological mechanisms underlying conditions like Alzheimer's, Parkinson's, and ALS. Studies focus on understanding how cellular dysfunction, including issues with protein folding, mitochondrial health, and endoplasmic reticulum stress, contributes to neuronal damage and loss. Researchers employ a range of methods, from molecular and cellular biology techniques to computational approaches like bioinformatics and genomic network analysis, to identify disease triggers and potential therapeutic targets. The work also examines receptor mechanisms and signaling pathways involved in neuronal communication and survival.

This research holds significant relevance for Arkansas's public health, particularly given the state's demographic profile and the growing burden of age-related diseases. Understanding these conditions can inform strategies for prevention, diagnosis, and treatment, potentially improving quality of life for many Arkansans and reducing healthcare costs. The economic impact extends to the development of new diagnostic tools and therapies, fostering innovation within the state's growing biomedical sector.

This area of study benefits from interdisciplinary collaborations, drawing on expertise in protein structure and dynamics, disease mechanisms, and bioinformatics. Engagement across multiple institutions in Arkansas allows for a comprehensive approach to tackling the complex challenges posed by neurodegenerative disorders.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Nirjal Mainali UAMS 8 188
Paavan Atluri University of Arkansas 2 55

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
5,618 works in 2026
-0.9% CAGR 2018–2026
Leadership concentration
7.5% held by global top 5 institutions
Fragmented HHI 31
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 Harvard University 2,182
  2. 2 Massachusetts General Hospital 1,800
  3. 3 Johns Hopkins University 1,755
  4. 4 National Institutes of Health 1,323
  5. 5 University of Pennsylvania 1,257

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Neurodegenerative Diseases.

48%
Paavan Atluri University of Arkansas
Browse All 2 Researchers in Directory